The Eurobact 1 study was a l arge multinational collaborative cohort study included patients from 162 ICUs in 24 countries thanks to the join effort of the National Coordinators and Investigators.
The study was awarded the Clinical Research aAard by the European Critical Care Research Network (ECCRN) of the ESICM in 2011.
5 scientific papers where published from Eurobact 1:
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.
Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.
Bloodstream infections in ICU with increased resistance: epidemiology and outcomes.
Update in hospital-acquired bacteremia respiratory infections: experience from the EUROBACT study
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study.